- Home
- HSII vs QURE Comparison
HSII vs QURE Comparison
Compare HSII & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- QURE
- Stock Information
- Founded
- HSII 1953
- QURE 1998
- Country
- HSII United States
- QURE Netherlands
- Employees
- HSII N/A
- QURE N/A
- Industry
- HSII Diversified Commercial Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- HSII Consumer Discretionary
- QURE Health Care
- Exchange
- HSII Nasdaq
- QURE Nasdaq
- Market Cap
- HSII 1.1B
- QURE 866.3M
- IPO Year
- HSII 1999
- QURE 2007
- Fundamental
- Price
- HSII $49.88
- QURE $16.49
- Analyst Decision
- HSII Buy
- QURE Strong Buy
- Analyst Count
- HSII 2
- QURE 11
- Target Price
- HSII $51.00
- QURE $39.91
- AVG Volume (30 Days)
- HSII 100.2K
- QURE 934.5K
- Earning Date
- HSII 11-03-2025
- QURE 11-04-2025
- Dividend Yield
- HSII 1.20%
- QURE N/A
- EPS Growth
- HSII N/A
- QURE N/A
- EPS
- HSII 1.60
- QURE N/A
- Revenue
- HSII $1,155,576,000.00
- QURE $14,337,000.00
- Revenue This Year
- HSII $11.33
- QURE N/A
- Revenue Next Year
- HSII $0.90
- QURE $301.10
- P/E Ratio
- HSII $31.11
- QURE N/A
- Revenue Growth
- HSII 9.00
- QURE N/A
- 52 Week Low
- HSII $35.90
- QURE $4.45
- 52 Week High
- HSII $52.18
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- HSII 54.10
- QURE 53.31
- Support Level
- HSII $49.05
- QURE $17.03
- Resistance Level
- HSII $51.51
- QURE $17.76
- Average True Range (ATR)
- HSII 1.15
- QURE 0.80
- MACD
- HSII -0.18
- QURE -0.03
- Stochastic Oscillator
- HSII 27.30
- QURE 41.55
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.